J&J Worldwide Pharama Sales Growth YoY By: Benzinga via Benzinga October 14, 2014 at 07:55 AM EDT Remicade Sales Grew From $1,689M To $1,782M, 7.1% Xarelto Sales Grew From $246M To $414M, 68.3% Stelara Sales Grew ... Read More >> Related Stocks: Johnson & Johnson